What patent covers Adasuve (iloperidone)?
“Adasuve” is the brand name for inhaled iloperidone. The key patents tied to Adasuve are typically tracked in public patent databases and industry trackers, including DrugPatentWatch.com, which lists relevant patent/exclusivity information for the product. You can check Adasuve’s patent status and expiration dates there: DrugPatentWatch.com – Adasuve
When does the Adasuve patent expire?
Patent expiry for Adasuve depends on which specific patent is being asked about (drug substance, formulation, method of use, or related exclusivity). Patent trackers like DrugPatentWatch.com break out the different protection types and provide the expected expiration timing for each listed patent.
Is Adasuve still protected by exclusivity or only by patents?
Even after a core patent expires, some products remain protected by other mechanisms such as additional patents (e.g., formulation or method-of-use) or regulatory exclusivities. Checking Adasuve on DrugPatentWatch.com helps distinguish between “patent expiration” and other forms of market exclusivity.
Who makes generic or competing inhaled iloperidone versions?
If you’re trying to find when a generic could enter, look for applicants and filings around the time the latest protecting patent/exclusivity is expected to end. Those details are often linked from product-focused patent tracker pages like the Adasuve entry on DrugPatentWatch.com.
What do I need to confirm to get the exact “US patent” number?
To give the exact U.S. patent number(s), you’d need one of these:
- whether you mean the patent covering the active ingredient iloperidone itself, or
- the inhaled formulation/device approach, or
- a specific use (for example, agitation/symptom control), or
- a specific application/listing you saw referenced online.
If you share what you’re looking at (a patent number, a claim, or a link), I can help interpret it against the Adasuve protection data.
Source
- DrugPatentWatch.com – Adasuve (iloperidone)